Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-03 Exercise | 2024-09-05 7:52 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 23,438 | $0 | 52,785 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 7:52 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 11,891 | $10.85 | 52,785 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 5:51 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 152,345 | $0 | 152,345 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 5:24 pm | N/A 2033-03-02 | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 168,750 | $0 | 168,750 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 8:45 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 10,553 | $6.11 | 17,801 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-05 8:45 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 18,850 | $0 | 17,801 (Direct) | View |
| 2022-06-14 Tax Withholding | 2022-06-16 5:03 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 9,346 | $7.73 | 28,354 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 5:03 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 18,850 | $0 | 28,354 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:03 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 18,850 | $0 | 28,354 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 8:31 pm | N/A 2032-01-14 | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 5:07 pm | N/A N/A | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 37,700 | $0 | 37,700 (Direct) | View |
| 2020-12-14 Option Award | 2020-12-17 06:07 am | N/A 2030-12-14 | IOVANCE BIOTHERAPEUTICS INC. | IOVA | Bellemin Jean-Marc Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 5:26 pm | 2020-04-01 2030-02-24 | Gritstone Oncology Inc. | GRTS | Bellemin Jean-Marc See Remarks | 110,000 | $0 | 110,000 (Direct) | View |